VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer
NCT01891708
·
clinicaltrials.gov ↗
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Brain Metastasis
Interventions
OTHER:
bevacizumab, standard chemotherapy and radiation
Sponsor
Li Liu